|
End-of-day quote
Dhaka S.E.
2026-09-09
|
5-day change | 1st Jan Change | ||
| 752.50 BDT | -0.05% |
|
+0.53% | +6.29% |
| Market Cap | 1.82B 14.79M 12.72M 11.98M 10.92M 20.42M 1.41B 20.5M 142M 54.87M 717M 55.52M 54.31M 2.27B | P/E 2024 |
189x | P/E 2025 | 369x |
|---|---|---|---|---|---|
| Enterprise Value | 2.32B 18.91M 16.27M 15.32M 13.96M 26.12M 1.8B 26.22M 182M 70.18M 917M 71M 69.46M 2.9B | EV / Sales 2024 |
10.4x | EV / Sales 2025 | 10.7x |
| Free-Float |
22.75% | Yield 2024 |
0.13% | Yield 2025 | 0.12% |
| 1 day | -0.05% | ||
| 1 week | +0.53% | ||
| Current month | -0.38% | ||
| 1 month | -6.49% | ||
| 3 months | -3.34% | ||
| 6 months | -2.68% | ||
| Current year | +6.29% |
| 1 week | 750 | 799.9 | |
| 1 month | 742.2 | 808 | |
| Current year | 689 | 847 | |
| 1 year | 681 | 847 | |
| 3 years | 650 | 1,302.3 | |
| 5 years | 375.3 | 1,302.3 | |
| 10 years | 353 | 1,302.3 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | - | - | |
| Director of Finance/CFO | - | - | |
| Chief Administrative Officer | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | - | - | |
| Director/Board Member | - | - | |
Nurjehan Hudda
BRD | Director/Board Member | - | - |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -0.05% | +0.53% | -9.67% | +14.41% | 14.69M | ||
| -1.11% | -3.46% | +17.16% | +64.97% | 47.73B | ||
| -2.10% | -6.62% | +37.45% | +113.68% | 40.21B | ||
| -1.58% | -2.32% | +8.86% | +79.48% | 12.05B | ||
| -1.51% | -3.52% | -12.15% | +9.52% | 11.79B | ||
| +0.38% | +0.19% | +19.18% | +137.27% | 9.16B | ||
| -0.13% | -5.62% | +34.94% | -17.57% | 7.39B | ||
| -1.60% | -1.02% | +15.06% | +213.45% | 7.37B | ||
| 0.00% | -1.72% | +20.96% | +33.90% | 7.34B | ||
| +1.32% | +0.10% | -43.62% | +22.77% | 5.13B | ||
| Average | -0.64% | -1.66% | +8.82% | +67.19% | 14.82B | |
| Weighted average by Cap. | -1.19% | -2.67% | +18.65% | +79.68% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 219M 1.79M 1.54M 1.45M 1.32M 2.47M 170M 2.48M 17.15M 6.63M 86.57M 6.71M 6.56M 274M | 231M 1.88M 1.62M 1.52M 1.39M 2.59M 179M 2.6M 18.03M 6.97M 91.01M 7.05M 6.9M 288M |
| Net income | 9.68M 78.86K 67.86K 63.89K 58.22K 109K 7.5M 109K 757K 293K 3.82M 296K 290K 12.11M | 5.31M 43.24K 37.2K 35.03K 31.92K 59.72K 4.11M 59.96K 415K 160K 2.1M 162K 159K 6.64M |
| Net Debt | 445M 3.62M 3.12M 2.93M 2.67M 5M 345M 5.02M 34.77M 13.44M 176M 13.6M 13.3M 556M | 506M 4.12M 3.55M 3.34M 3.04M 5.7M 392M 5.72M 39.59M 15.3M 200M 15.48M 15.15M 633M |
Employees
474
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-09-09 | BDT 752.50 | -0.05% | 878 |
| 26-09-08 | BDT 752.90 | -0.57% | 1,138 |
| 26-09-07 | BDT 757.20 | -0.26% | 952 |
| 26-09-06 | BDT 759.20 | +1.77% | 882 |
| 26-09-03 | BDT 746.00 | -0.33% | 1,521 |
- Stock Market
- Stocks
- AMBEEPHA Stock
Select your edition
All financial news and data tailored to specific country editions
















